Skip to main content

Advertisement

Log in

Surgical Intervention and Its Clinical Significance of Gastrointestinal Metastasis from Lung Cancer: A Series of 14 Cases

  • Original Article
  • Published:
Indian Journal of Surgery Aims and scope Submit manuscript

Abstract

Gastrointestinal (GI) metastasis from lung cancer generally suggests the end-stage of the disease because it is already part of the systemic dissemination, thereby indicating poor prognosis. Its symptoms, such as perforation and hemorrhage, are frequently emergent, and immediate clinical decision is warranted, given the patient’s poor prognosis. Herein, we reported 14 cases of GI metastasis from lung cancer who underwent surgery in our department. The mean age was 63 years. The most frequent site and symptom of GI metastasis were the small intestine (64%) and hemorrhage (43%), respectively. Perforation occurred in three of the patients (21%), showing the worst prognosis compared with hemorrhage and obstruction. The median survival was 101 days (19–1651 days). The clinical and pathological factors of these patients were investigated. As evaluated in our case series, long-term survival might be achieved through resection with no residual tumor and with early detection of GI metastasis. Surgeons need to consider such insight when being consulted for patients who have lung cancer with abdominal symptoms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Torre LA, Siegel RL, Jemal A (2016) Lung Cancer Statistics. Adv Exp Med Biol 893:1–19

    Article  Google Scholar 

  2. Antler AS, Ough Y, Pitchumoni CS, Davidian M, Thelmo W (1982) Gastrointestinal metastases from malignant tumors of the lung. Cancer 49(1):170–172

    Article  CAS  Google Scholar 

  3. Politi K, Herbst RS (2015) Lung cancer in the era of precision medicine. Clin Cancer Res 21(10):2213–2220

    Article  CAS  Google Scholar 

  4. Riihimäki M, Hemminki A, Fallah M et al (2014) Metastatic sites and survival in lung cancer. Lung Cancer 86(1):78–84

    Article  Google Scholar 

  5. Galanopoulos M, Gkeros F, Liatsos C (2018) Secondary metastatic lesions to colon and rectum. Ann Gastroenterol 31(3):282–287

    PubMed  PubMed Central  Google Scholar 

  6. Conner JR, Hornick JL (2015) Metastatic carcinoma of unknown primary: diagnostic approach using immunohistochemistry. Adv Anat Pathol 22(3):149–167

    Article  CAS  Google Scholar 

  7. Goh BK, Yeo AW, Koong HN, Ooi LL, Wong WK (2007) Laparotomy for acute complications of gastrointestinal metastases from lung cancer: is it a worthwhile or futile effort? Surg Today 37(5):370–374

    Article  Google Scholar 

  8. Rossi G, Marchioni A, Romagnani E, Bertolini F, Longo L, Cavazza A, Barbieri F (2007) Primary lung cancer presenting with gastrointestinal tract involvement: clinicopathologic and immunohistochemical features in a series of 18 consecutive cases. J Thorac Oncol 2(2):115–120

    Article  Google Scholar 

  9. Lee PC, Lo C, Lin MT, Liang JT, Lin BR (2011) Role of surgical intervention in managing gastrointestinal metastases from lung cancer. World J Gastroenterol 17:4314–4320

    Article  Google Scholar 

  10. Ferrara N, Gerber HP, LeCouter J (2003) The biology of VEGF and its receptors. Nat Med 9:669–676

    Article  CAS  Google Scholar 

  11. Hurwitz H, Fehrenbacher L, Novotny W et al (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 23:2335–2342

    Article  Google Scholar 

  12. Aghajanian C, Blank SV, Goff BA, Judson PL, Teneriello MG, Husain A, Sovak MA, Yi J, Nycum LR (2012) OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer. J Clin Oncol 30:2039–2045

    Article  CAS  Google Scholar 

  13. Pujade-Lauraine E, Hilpert F, Weber B, Reuss A, Poveda A, Kristensen G, Sorio R, Vergote I, Witteveen P, Bamias A, Pereira D, Wimberger P, Oaknin A, Mirza MR, Follana P, Bollag D, Ray-Coquard I (2014) Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: the AURELIA open-label randomized phase III trial. J Clin Oncol 32:1302–1308

    Article  CAS  Google Scholar 

  14. Thomford NR, Woolner LB, Clagett OT (1965) The surgical treatment of metastatic tumors in the lungs. J Thorac Cardiovasc Surg 49:357–363

    Article  CAS  Google Scholar 

  15. Rivas H, Díaz-Calderón D (2013) Present and future advanced laparoscopic surgery. Asian J Endosc Surg 6:59–67

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ryota Koyama.

Ethics declarations

•Conflict of Interest

We declare that we have no conflicts of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Koyama, R., Minagawa, N., Maeda, Y. et al. Surgical Intervention and Its Clinical Significance of Gastrointestinal Metastasis from Lung Cancer: A Series of 14 Cases. Indian J Surg 82, 540–544 (2020). https://doi.org/10.1007/s12262-019-02037-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12262-019-02037-5

Keywords

Navigation